Documents et rapports
-
Pharmaceutical Policy in Lebanon - Rapid Assessment and Recommendations (anglais)
The current multi-faceted crisis in Lebanon has affected all aspects of life, with a large part of the population now living in poverty. The health sector has been heavily affected by these developments...
Type de document: Rapport Numéro du rapport: 191366 Date du document: 20 mars 2024 Mode de publication: Disclosed Auteur: Andreas Seiter
-
Value Chain Investment Plan : Medicine, Pharmaceutical and Biotechnology (anglais)
In January 2019, the Belarusian Ministry of Economy, the European Union (EU), and the World Bank launched the EU–Belarus Private Sector Development Program to support the Belarusian government’s efforts...
Type de document: Rapport Numéro du rapport: 168485 Date du document: 31 décembre 2023 Mode de publication: Disclosed Auteur: Lapres,Blair Edward
-
Western and Central Africa - Sub-Saharan Africa Women’s Empowerment and Demographic Dividend Plus (SWEDD+) Project (anglais)
The objective of the Sub-Saharan Africa Women’s Empowerment and Demographic Dividend Plus (SWEDD+) Project is to increase girls’ and women’s access to learning, economic opportunities, and utilization...
Type de document: Document d’évaluation du projet Numéro du rapport: PAD5032 Date du document: 8 septembre 2023 Mode de publication: Disclosed Auteur: World Bank
-
IFC and Estonia, Latvia, Lithuania - Partners in Private Sector Development (anglais)
IFC maintains a focused relationship with the Baltic countries, which revolves around engagement with select companies in the fintech and tech, forestry, logistics, agribusiness and retail sectors, which...
Type de document: Fiche Numéro du rapport: 188280 Date du document: 1 septembre 2023 Mode de publication: Disclosed Auteur: World Bank
-
Learning from Best Practices : An Overview of the Republic of Korea Pharmacovigilance System (anglais)
Building capacity in countries to conduct thorough surveillance of the use of all newly authorized drugs and vaccines, both brand name and generic, is a critical “public good” investment to ensure that...
Type de document: Rapport Numéro du rapport: 184491 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Marquez,Patricio V.,Figueras Sune,Albert-Jesus,Kseniya Bieliaieva
-
Pharmacovigilance Situation Analysis Report : Safety Monitoring of Medicines and Vaccines (anglais)
Medicines, vaccines, medical devices, and blood are commonly used to treat disease. Medicines deserve a special focus because almost any medical visit ends with at least one prescription. So, monitoring...
Type de document: Rapport Numéro du rapport: 184487 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Marquez,Patricio V.,Figueras Sune,Albert-Jesus,Kseniya Bieliaieva
-
The Caribbean Regulatory System : A Subregional Approach for Efficient Medicine Registration and Vigilance (anglais)
This report focuses on the Caribbean Public Health Agency (CARPHA), one of the three multi-national public health agencies in the world, that commenced operations on Jan 1, 2013, with the aim of delivering...
Type de document: Rapport Numéro du rapport: 184489 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Figueras Sune,Albert-Jesus,Extavour, Rian Marie,Marquez,Patricio V.,Kseniya Bieliaieva
-
Starting and Strengthening a National Pharmacovigilance System : The Case of Catalan Regional Activities that Propelled the Spanish Pharmacovigilance System (anglais)
The Spanish System of Pharmacovigilance (SSPV) started its activities almost 40 years ago, in 1985. Of particular interest to others considering various options for developing pharmacovigilance systems...
Type de document: Rapport Numéro du rapport: 184493 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Figueras Sune,Albert-Jesus,Marquez,Patricio V.,Kseniya Bieliaieva
-
Positioning Report on Pharmacovigilance : The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID (anglais)
Although indispensable for improving health outcomes, medicines and vaccines or their administration and use can produce adverse effects, requiring continuous vigilance to ensure that the benefits outweigh...
Type de document: Rapport Numéro du rapport: 184486 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Marquez,Patricio V.,Figueras Sune,Albert-Jesus,Kseniya Bieliaieva
-
Learning from the Republic of Korea : Building Health System Resilience (anglais)
The response of the government of the Republic of Korea to COVID-19 has been heralded as among the most successful. In the first two years of the pandemic, the government was able to keep the size of the...
Type de document: Rapport Numéro du rapport: 184490 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Hwang,Inuk,Marquez,Patricio V.
-
Pharmacovigilance in Brazil : Creating an Effective System in a Diverse Country (anglais)
The ability to oversee and monitor the use of all newly authorized drugs and vaccines, both brand name and generic, is critical to ensure that they work correctly and that their health benefits outweigh...
Type de document: Rapport Numéro du rapport: 184492 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Figueras Sune,Albert-Jesus,Marquez,Patricio V.,Kseniya Bieliaieva
-
Realizing a Regional Approach to Pharmacovigilance : A Review of the European Union Approach (anglais)
This report reviews the pharmacovigilance system of the European Union (EU) mapping out its structure and processes with any eye to features that may be of particular interest to decision makers in other...
Type de document: Rapport Numéro du rapport: 184488 Date du document: 10 août 2023 Mode de publication: Disclosed Auteur: Wang,Huihui,Marquez,Patricio V.,Figueras Sune,Albert-Jesus,Kseniya Bieliaieva
-
Why Is the Safety of Medicines Important for Resilient Health Systems? (anglais)
This paper discusses the importance of pharmacovigilance (PV) in contributing to building up resilient health systems. Although indispensable in improving health outcomes, the administration and use of...
Type de document: Rapport Numéro du rapport: 183380 Date du document: 27 juin 2023 Mode de publication: Disclosed Auteur: World Bank
-
Pharmaceutical Framework Contracting in Liberia - A Knowledge and Learning Exploratory Study (anglais)
Only 2.2 percent of Liberia's total annual public health spending is spent on essential medicines and medical commodities. This has been one of the main reasons for frequent stockouts of essential medicines...
Type de document: Rapport Numéro du rapport: 183545 Date du document: 1 avril 2023 Mode de publication: Disclosed Auteur: World Bank
-
Investment Case: Optimisation of Medical Distribution in Mozambique (anglais)
A 2018 survey found that only 55% of health facilities in Mozambique have priority drugs in stock and not expired. Availability of commodities at service points remains a challenge and is targeted for...
Type de document: Rapport Numéro du rapport: 191178 Date du document: 30 septembre 2021 Mode de publication: Disclosed Auteur: World Bank
-
Содействие развитию конкурентоспособности в Республике Беларусь (russe)
В Республике Беларусь имеется ряд естественно сформированных кластеров, играющих важную роль в развитии экономики страны. Эти кластеры не являются формальными структурами, а представляют собой группы взаимосвязанных...
Type de document: Rapport Numéro du rapport: AUS0002207 Date du document: 1 juin 2021 Mode de publication: Disclosed Auteur: Shanthi Divakaran,Blair Edward Lapres,Sanchez,Carlos
-
Value Chain Investment Plan : Medicine, Pharmaceutical and Biotechnology (anglais)
In January 2019, the Belarusian Ministry of Economy, the European Union (EU), and the World Bank launched the EU–Belarus Private Sector Development Program to support the Belarusian government’s efforts...
Type de document: Rapport Numéro du rapport: 168485 Date du document: 31 décembre 2020 Mode de publication: Disclosed Auteur: Lapres,Blair Edward
-
Value Chain Investment Plan : Medicine, Pharmaceutical and Biotechnology (anglais)
In January 2019, the Belarusian Ministry of Economy, the European Union (EU), and the World Bank launched the EU–Belarus Private Sector Development Program to support the Belarusian government’s efforts...
Type de document: Rapport Numéro du rapport: 168485 Date du document: 31 décembre 2020 Mode de publication: Disclosed Auteur: Lapres,Blair Edward
-
Report on Cluster Potential and Strategies : Medicine, Pharmaceutical and Biotechnology (anglais)
In January 2019, the Belarusian Ministry of Economy, the European Union (EU), and the World Bank launched the EU-Belarus Private Sector Development Program to support the government’s efforts to foster...
Type de document: Rapport Numéro du rapport: 168490 Date du document: 1 novembre 2020 Mode de publication: Disclosed Auteur: Lapres,Blair Edward
-
Promoting Competitiveness in Belarus : Recommendations for the Dairy, Information Technology, Instrument Making, and Pharmaceutical Sectors (anglais)
Several natural clusters have been important for Belarus’ development. These clusters are not formal entities. Instead, they are groups of interrelated companies, organizations, and service providers—linked...
Type de document: Rapport Numéro du rapport: AUS0002207 Date du document: 1 juin 2020 Mode de publication: Disclosed Auteur: Divakaran,Shanthi,Lapres,Blair Edward,Sanchez,Carlos